The latest on the CDC panel decision about the J&J vaccine

Morning Bullets header logo

Your daily source for trading strategies, tech news, and politically incorrect humor.

Hey there, Bullets Fans –

Your Morning Bullets Brief Updates are here! And that means trivia is, too.

Who said the following: “It always seems impossible until it is done.”

Think you know the answer? You can check it in the closing area down below!

Five things you need to know before you start your day

Image Source: CNBC

After a slew of better-than-anticipated earnings reports, stock futures indicated gains for the major benchmarks this morning. Investors were digesting the latest financial data from Bank of America, Pepsi, and United Health. Each of the three companies surpassed estimates, leading shares to increase.

Meanwhile, the retail sales report for March is out this morning, and analysts anticipate a 6.1% increase, boosted by the recent $1,400 stimulus checks, increased vaccinations, and a reopening economy. The news would come after a 3% decline in February.

Also out this morning: the Labor Department’s latest look at initial jobless claims for last week. Economists are expecting to see 710,000 new filings, which would reflect a decline from the prior week.

And Coinbase Global saw an 8% increase in shares during premarket trading, after yesterday’s strong (albeit volatile) debut.

What else should you know about the market this morning?

Other News That Matters To You:

This incredible stock was hiding in plain sight — here’s what you need to know


Recommended Link:
Click Here
Perfect Stock Caught Trading Under Secret Name

This is just bizarre…

We have just uncovered perhaps the most unusual stock we’ve ever seen.

It’s expected to see massive revenue in 2020 – $100 billion.

The company holds over 29,000 patents in the U.S.

It pays an enormous dividend.

And yet…

It’s ultra-cheap – less than $3.


The latest on the CDC panel decision about the J&J vaccine

Image Source:  Getty Images

Dr. Anthony Fauci had previously said the pause on the Johnson & Johnson vaccine would likely last a mere matter of days. But, like with so much else this past year, he was wrong. Yesterday a panel for the Centers for Disease Control and Prevention met to discuss the vaccine as it relates to the cases of rare but serious blood clots in six women so far.

However, the committee ultimately decided to postpone their recommendation as the investigation continues. The panel will get back together next week and determine what to do next.

This means that the single-dose Johnson & Johnson vaccine will remain off the market.

What else do we know about the cases so far, and what did some members of the panel have to say about it all?

More Headline You Need To Read:

Thanks for reading once again! And don’t worry, I didn’t forget:

Here’s where you can go to check your answer!

Know someone who should be getting these Bullet Briefs? Make sure to send them over to to subscribe.

Your biggest fan,


Fredrick Frost

P.S.  How useful did you find today’s Morning Bullets? 

Not useful – 22.81%

It was ok – 13.11%

It was good – 38.31%

Very useful – 25.77%


Note: Percentages are updated once per week on Sundays and include all feedback since inception.

Author: Fredrick Frost

Fedrick Frost is the Editor-in-Chief of Morning Bullets. He mainly writes about Politics, The Economy and breaking news. With over 35 years in jounralism he has been influential in helping the morning bullets newsletter readers be informed every morning.